Chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD) not only
have smoking as a common risk factor, they also share epidemiological relationships and …

Background Patients with chronic obstructive pulmonary disease (COPD) are at risk of
developing cardiac arrhythmias and elevated heart rate. A theoretical mechanistic …

Associations between patient characteristics or treatments received and clinical outcomes
are often first described using observationaldata, suchasdataarisingthroughusualclinicalcare …

COPD is a major healthcare problem and cause of mortality worldwide. COPD patients at
increased mortality risk are those who are more symptomatic, have lower lung function and …

Purpose: Many comorbidities, including depression, anxiety, and insomnia, occur in patients
with chronic obstructive pulmonary disease (COPD). These patients may be prescribed …

Introduction Assessing clinically important measures of disease progression is essential for
evaluating therapeutic effects on disease stability in chronic obstructive pulmonary disease …

Background: Patients with chronic obstructive pulmonary disease (COPD) are at risk for
pulmonary hypertension (PH). The aim of our study was to investigate the benefit of statins …

Background It has been noted that there is an increase in the incidence of acute
cardiovascular events (CVEs) in patients with chronic obstructive pulmonary disease …

ABSTRACT Introduction: Long-acting β2-adrenoceptor (β2-AR) agonists (LABAs) plus long-
acting muscarinic antagonists (LAMAs) is the cornerstone for treating chronic obstructive …

Background While inhaled bronchodilators reduce symptoms and acute exacerbations of
chronic obstructive pulmonary disease (COPD), their use is associated with increased …